BryanDavidKraftMDFCCP
Pulmonology • Saint Louis, MOCritical Care Medicine
Associate Professor of Medicine, Director of Medical Critical Care and Medical Intensive Care Units, Washington University School of Medicine in St. Louis
Dr. Kraft is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110Phone+1 314-454-8762Fax+1 314-454-7524
Summary
- Dr. Kraft has a wide variety of clinical and research interests, including sepsis, pneumonia, and acute respiratory distress syndrome (ARDS), and has special expertise in rare lung diseases such as pulmonary fibrosis and pulmonary alveolar proteinosis (PAP). Dr. Kraft’s research laboratory is devoted to understanding mechanisms of acute lung injury resolution, and uses translational models and clinical patient samples to identify novel pathways of recovery. Dr. Kraft is also an active investigator in clinical trials to develop new therapies for patients with lung diseases.
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013- Duke University HospitalResidency, Internal Medicine, 2007 - 2010
University of Tennessee Health Science Center College of MedicineClass of 2007
Certifications & Licensure
MO State Medical License 2021 - 2025
FL State Medical License 2019 - 2023
NC State Medical License 2007 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Hyperbaric VO2max Study Start of enrollment: 2015 Feb 01
- Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS) Start of enrollment: 2015 Apr 01
- Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis Start of enrollment: 2016 Mar 21
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsSchizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literatureBryan Kraft, Eric C. Westman
Nutrition & Metabolism. 2009-02-26 - 12 citationsNuclear respiratory factor-1 negatively regulates TGF-β1 and attenuate pulmonary fibrosisHagir B. Suliman, Zachary R. Healy, Fabio Zobi, Bryan Kraft, Karen E. Welty-Wolf
Iscience. 2021-11-30 - 71 citationsA phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDSLaura E. Fredenburgh, Mark A. Perrella, Diana Barragan-Bradford, Dean R. Hess, Elizabeth Peters
JCI Insight. 2018-12-06
Journal Articles
- Pulmonary Arterial Hypertension: Screening, Management, and Treatment [Internet]McCrory DC, Coeytaux RR, Schmit KM, Kraft B, Kosinski AS, Mingo AM, Vann LM, Gilstrap DL, Hargett CW, Lugogo NL, Heidenfelder BL, Posey R, Irvine RJ, Wing L, Pendergas..., Rockville (MD): Agency for Healthcare Research and Quality (US), 4/2013
Books/Book Chapters
Press Mentions
Still No Consensus on Antibiotics for Persistent Sinus InfectionFebruary 6th, 2017
Inhaled CO Is Tested as ARDS TherapyJanuary 31st, 2017
Could Carbon Monoxide Be Used to Manage Sepsis-Related Lung Injury? – an Interview with Bryan Kraft, MDFebruary 22nd, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
